PDCD1 and paronychia: Immune‐related AEs associated with anti‐PD‐1 therapy occurred in three patients who experienced one or more of the following events: cheilitis, thyroiditis, hypothyroidism, blisters, paronychia, temperature intolerance, paresthesia, and fatigue.